During the past decade, Ekrem Aksu conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ekrem Aksu" are "Coronary Artery Disease" (1 trials), "Myocard Infarctus" (1 trials) and "Progression of Atherosclerotic Plaque" (1 trials). Many other conditions were trialed in "Ekrem Aksu" in a lesser frequency.

Most popular intervention types in "Ekrem Aksu" are "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Comparison of oxidative and antioxidative markers between groups" (1 trials) and "Coronary Angiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ekrem Aksu" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ekrem Aksu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ekrem Aksu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ekrem Aksu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".